mesalamine has been researched along with technetium tc 99m exametazime in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Annovazzi, A; Biancone, L; Caprilli, R; Capriotti, G; Caviglia, R; Chianelli, M; Mather, SJ; Pallone, F; Scopinaro, F; Signore, A | 1 |
1 trial(s) available for mesalamine and technetium tc 99m exametazime
Article | Year |
---|---|
99mTc-interleukin-2 and (99m)Tc-HMPAO granulocyte scintigraphy in patients with inactive Crohn's disease.
Topics: Crohn Disease; Disease-Free Survival; Female; Granulocytes; Humans; Interleukin-2; Intestines; Male; Mesalamine; Middle Aged; Organotechnetium Compounds; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Secondary Prevention; Sensitivity and Specificity; Technetium Tc 99m Exametazime | 2003 |